Paltac Corporation

Paltac Corporation, headquartered in Japan and operating in the Pharmaceutical Preparation Manufacturing industry, reported its most recent Scope 1, 2, and 3 emissions for 2025.

In 2025, Paltac Corporation's reported emissions were:

• Scope 1: 2,589,000 kg CO2e
• Scope 2: 17,746,000 kg CO2e
• Scope 3: 6,617,924,000 kg CO2e. Key categories within Scope 3 include approximately 5,942,301,000 kg CO2e from purchased goods and services, 624,762,000 kg CO2e from end-of-life treatment of sold products, and 29,500,000 kg CO2e from upstream transportation and distribution.

Comparing this to previous years:

• In 2024, the company reported Scope 1 emissions of 2,627,000 kg CO2e, Scope 2 emissions of 18,756,000 kg CO2e, and Scope 3 emissions of 6,399,566,000 kg CO2e.
• In 2023, Paltac Corporation's reported Scope 1 emissions were 3,262,000 kg CO2e, Scope 2 emissions were 18,519,000 kg CO2e, and Scope 3 emissions were 6,189,933,000 kg CO2e.

For 2022 and 2021, only Scope 1 and 2 emissions were disclosed. In 2022, these were 3,267,000 kg CO2e (Scope 1) and 20,229,000 kg CO2e (Scope 2). In 2021, they were 3,293,000 kg CO2e (Scope 1) and 21,797,000 kg CO2e (Scope 2).

In 2020, the company disclosed a total of approximately 51,052,000 kg CO2e across all scopes, comprising 3,284,000 kg CO2e (Scope 1), 20,703,000 kg CO2e (Scope 2), and 27,065,000 kg CO2e (Scope 3). For 2019, Scope 1 emissions were 3,722,000 kg CO2e and Scope 2 emissions were 22,441,000 kg CO2e.

Paltac Corporation does not currently have any public document-based reduction targets, SBTi reduction targets, or a Climate Pledge. Emissions data for Paltac Corporation is directly reported by the company.